Table 2. Median RAS peptide concentrations in ARDS patients at study entry.

RAS peptide	Median Concentration (ng/mL) (interquartile range)
	Non-survivors (N = 19)	Survivors (n = 20)	p-value
A(1–12)	0.05 (0.05–0.64)	0.05 (0.05–1.97)	0.875
A(1–10)	5.86 (1.99–16.95)	2.33 (0.73–5.66)	0.012
A(1–9)	1.14 (0.10–2.82)	1.55 (0.55–3.08)	0.216
A(1–8)	0.38 (0.12–0.63)	0.76 (0.07–2.22)	0.298
A(1–7)	0.19 (0.12–0.61)	0.63 (0.08–1.07)	0.203